The diagnosis of nonmalignant diseases related to asbestos.

نویسندگان

  • A Franzblau
  • R Lilis
چکیده

Objective The health effects of asbestos have become a cause of serious concern in recent years. It has been estimated that from 1940 to 1979, in the United States alone, 27,500,OOO individuals were. exposed to this mineral at work. Recognition of the diseases caused by asbestos exposure has led manufacturers to reduce exposure in a variety of ways, such as by using alternative materials and by instituting improved work practices. It has also led to widespread public concern over the presence of asbestos in the environment, and fear on the part of persons with minimal exposure. This and projections of future asbestos related illness have posed important public policy questions-whether to remove all asbestos in public buildings and what to do about the enormous estimated legal liability. In this context, physicians are commonly asked for advice Furthermore, they are also consulted regarding the diagnosis of an asbestos-related respiratory condition in’ an exposed individual. While abundant literature exists on the health effects of asbestos, there is much that is conflicting. Accordingly, this report has been prepared by a group of experts to present an authoritative consensus view of the current state of knowledge while pointing out areas where additional information is necessary. An attempt is made to summarize our present knowledge on the diagnosis of nonmalignant asbestos-related pulmonary disease and provide the sources on which the opinion is based.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Diagnosis and initial management of nonmalignant diseases related to asbestos.

Diagnostic Criteria and Guidelines for Documenting Them Asbestos as a Hazard Asbestos in Lung Tissue Clinical Evaluation and Indicators Symptoms Occupational and Environmental History Physical Examination Conventional Imaging Computed Tomography Bronchoalveolar Lavage Pulmonary Function Tests Nonmalignant Disease Outcomes Asbestosis Nonmalignant Pleural Abnormalities Associated with Asbestos Ch...

متن کامل

Asbestos-related Lung Diseases: A Brief Update

Health risks from asbestos exposures have been evaluated, considering past professional histories when exposures at workplaces were higher than today. A linear no-threshold (LNT) model has been applied, although its relevance is unproven. Fibers are often found in the lungs and pleura of deceased people. Fiber findings do not prove that a disease is caused by asbestos. It is reasonable to assum...

متن کامل

THE DIAGNOSIS OF NONMALIGNANT DISEASES RELATED TO ASBESTOS THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, MARCH 1986. Objective

The health effects of asbestos have become a cause of serious concern in recent years. It has been estimated that from 1940 to 1979, in the United States alone, 27,500,000 individuals were exposed to this mineral at work. Recognition of the diseases caused by asbestos exposure has led manufacturers to reduce exposure in a variety of ways, such as by using alternative materials and by institutin...

متن کامل

Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis

BACKGROUND The mortality from all malignant and nonmalignant asbestos-related diseases remains unknown. The authors assessed the incidence and risk factors for all asbestos-related deaths. METHODS The sample included 544 patients from an asbestos-exposed community in the area of Barcelona (Spain), between Jan 1, 1970, and Dec 31, 2006. Competing risk regression through a subdistribution hazar...

متن کامل

Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.

BACKGROUND Malignant pleural mesothelioma (MPM) results from malignant transformation of mesothelial cells. Past asbestos exposure represents a major risk factor for MPM and other benign pleural disease. Soluble mesothelin-related peptides (SMRP) have been regarded as a promising serum biomarker for MPM. The aim of this study was to investigate serum levels of SMRP in malignant and nonmalignant...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The American review of respiratory disease

دوره 136 6  شماره 

صفحات  -

تاریخ انتشار 1986